Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2012

Oct 5, 2012

30198_dirs_2012-10-05_1d0e52f3-88b6-408f-af05-274ee3f13fde.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2012-10-03

Reporting Person: GREGG TERRANCE H (Director, CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-10-03 Common Stock S 5000 $14.93 Disposed 935889 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 30000 Direct
Common Stock 11461 Indirect

Footnotes

F1: On November 21, 2011, Mr. Gregg adopted a 10b5-1 Plan. Under the 10b5-1 Plan, Mr. Gregg will sell a limited number of shares to cover the tax liability that accrues upon monthly vesting of restricted stock units previously granted to Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Included in this number are 24,375 unvested restricted stock units granted on March 12, 2010, 4,062 of which shall vest each month through March 12, 2013; 91,407 unvested restricted stock units granted on March 8, 2011, 5,078 of which shall vest each month through March 8, 2014; and 152,345 unvested restricted stock units granted on March 8, 2012, 5,078 of which shall vest each month through March 8, 2015.

F3: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.